As of November 10, 2020

Dividends Policy

Considering the management performance and financial condition overall, Takara Bio recognizes a basic policy aimed for profit contribution, positioning the profit distribution to shareholders as an important issue for management as well as enhancing the internal reserves to strengthen the R&D activities of three business segments: Bioindustry, Gene Therapy, and AgriBio businesses.

  Specifically, our policy calls for a target rate of around 20% of estimated profit calculated without considering extraordinary income or loss in the consolidated financial statements.

 

Dividend Trends

FY2018 FY2019 FY2020 FY2021 FY2022 FY2023
(Expected)
Dividend Per Share(yen) 1Q ------
2Q 0.000.000.000.000.000.00
3Q ------
FY-End 4.507.008.0016.0033.0033.00
Total 4.507.008.0016.0033.0033.00
Amount of Dividends(million yen) 5418429631,9263,973-
Payout Ratio(%) 23.223.025.220.220.037.5
Ratio of Total Amount of Dividends to Net Assets(%) 0.91.31.52.74.7-

Share Buybacks

We have not bought back our shares as of today.